Lobbying registration dated 2026-01-12
Registrant: Adele Fifield
Client: National Association of Pharmacy Regulatory Authorities
Targeted institutions:
Employment and Social Development Canada (ESDC)
Public Safety Canada (PS)
Finance Canada (FIN)
Treasury Board Of Canada Secretariat (TBS)
Prime Minister's Office (PMO)
House of Commons
Innovation, Science and Economic Development Canada (ISED)
Indigenous Services Canada (ISC)
Competition Bureau Canada (COBU)
Office of the Privacy Commissioner of Canada (OPC)
Public Health Agency of Canada (PHAC)
Patented Medicine Prices Review Board (PMPRB)
Global Affairs Canada (GAC)
Immigration, Refugees and Citizenship Canada (IRCC)
Senate of Canada
Health Canada (HC)
Acts: Controlled Drugs and Substances Act
Food and Drugs Act
Government funding received:
Lobbying activity details:
Compounding and Outsourced Drug Preparation - Provide pharmacy regulatory perspectives related to the interplay between compounding, manufacturing and Outsourced Drug Preparation, where ODP is a separate category of activity under federal oversight distinguished from compounding and manufacturing, as well as work related to compounding and ODP in situations when manufactured products are not available or accessible.
Legislation and regulations affecting pharmacy practice – Provide pharmacy regulatory perspectives related to legislation and regulations that affect pharmacy practice, including legislative and regulatory requirements for health products distributed by pharmacy professionals (prescription drugs, medical devices), and coverage (national pharmacare).
Self-care products - Provide pharmacy regulatory perspectives related to the appropriate federal oversight of non-prescription drugs and other self-care products as regulated under the Food and Drugs Act or other legislation and regulations
Foreign Credential Recognition Program, Employment and Social Development, Health Canada Health Human Resources (HHR) Strategy – provide pharmacy regulatory perspectives related to labour mobility of pharmacy professionals across the country, including federal investments to improve support for the pharmacy workforce.
Controlled Drugs and Substances Act - Provide pharmacy regulatory perspectives related to updating the CDSA and its associated regulations that may affect the practice of pharmacy, including pharmacists as practitioners/ prescribers of controlled substances.
Drug Shortages - Provide pharmacy regulatory perspectives on work being done nationally regarding drug shortages and accessibility of needed medications in Canada.